Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Dermatology OTC Switches Loom Next For Consumer Health Growth

Executive Summary

Dermatology OTC switch products for acne, eczema and psoriasis are likely to emerge, says Kline analyst Laura Mahecha. Switches, the return of recalled OTC brands and market consolidation drove a 4.2% increase for the US consumer health market in 2015.

Advertisement

Related Content

J&J Invests In Consumer Business For Long Haul, Not Quick Sale
Differin Gel Enters Changed Marketplace Since Last OTC Acne Drug Approval
Sanofi 'Fine-Tuning' Cialis OTC Switch Application
Bayer Shoulders Marketing Spend To Lift Consumer Product Sales
'Migraine Experience' Debuts Excedrin Advertising By Glaxo/Novartis JV
Merck Silence On OTC Singulair Speaks Volumes On Switch Outlook
CAGR For OTC Switch Forecast At 5%, But Without Statins, Asthma Treatments
Rhinocort Switch Makes Three In OTC Intranasal Corticosteroid Market

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS119247

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel